Sep 01, 2026
Pfizer (PFE) Stock Surges to 52-Week Peak Following Strong Q2 Results and Major Legal Settlement
Pfizer (PFE) stock touched a 52-week high of $29.09 after Q2 earnings exceeded forecasts and the company settled over 6,000 Depo-Provera lawsuits.
The post Pfizer (PFE) Stock Surges to 52-Week Peak Following Strong Q2 Results and Major Legal Settlement appeared first on Blockonomi.
Source: Blockonomi →Related News
- 43 minutes ago
Nasdaq Futures Rise as Tech Optimism and Middle East Oil News Drive Markets
- 44 minutes ago
Nvidia (NVDA) Stock Gains 1.6% as CEO Jensen Huang Pushes Back Against AI Regula...
- 45 minutes ago
Tesla (TSLA) Stock Gains Momentum Following First-Ever Fitch BBB Rating
- 46 minutes ago
Micron (MU) Stock Slides as Taiwan Plant Faces Strike Threat Over Profit-Sharing...
- 1 hour ago
SpaceX (SPCX) Stock: Morgan Stanley Highlights Power Infrastructure as Key AI Di...
